Clinical trial
Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed…
NCT00262834 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00262834 |
|---|---|
| Title | Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer |
| Official title | A Pilot Study Evaluating Surrogates of Response to Short Term Oral Suberoylanilide Hydroxamic Acid (SAHA) in Women With Newly Diagnosed Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | vorinostat, conventional surgery |
| Enrollment | 54 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | May 1, 2013 |
| First posted | Dec 7, 2005 |
| Last update posted | Feb 19, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: